Birdwatch Archive

Birdwatch Note

2023-06-07 12:52:11 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

COVID-19 vaccines are not experimental. The primary endpoint of the COVID-19 vaccine trial was symptomatic infection, secondary endpoint severe disease. All endpoints in the clinical trials were met. Transmission studies were done through secondary observational studies https://www.nejm.org/doi/full/10.1056/nejmoa2034577 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00648-4/fulltext https://www.nejm.org/doi/full/10.1056/nejmoa2116597 https://www.nejm.org/doi/full/10.1056/nejmc2107717

Written by F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1666176143773298690

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1666427835655831555
  • noteId - 1666427835655831555
  • participantId -
  • noteAuthorParticipantId - F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D Participant Details
  • createdAtMillis - 1686142331409
  • tweetId - 1666176143773298690
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • COVID-19 vaccines are not experimental. The primary endpoint of the COVID-19 vaccine trial was symptomatic infection, secondary endpoint severe disease. All endpoints in the clinical trials were met. Transmission studies were done through secondary observational studies https://www.nejm.org/doi/full/10.1056/nejmoa2034577 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00648-4/fulltext https://www.nejm.org/doi/full/10.1056/nejmoa2116597 https://www.nejm.org/doi/full/10.1056/nejmc2107717

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-06-07 12:52:11 UTC
(1686142331409)
1969-12-31 23:59:59 UTC
(-1)
2023-06-08 02:08:54 UTC
(1686190134085)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-06-07 16:09:14 -0500 Rating Details
2023-06-07 15:31:29 -0500 Rating Details
2023-06-07 15:20:18 -0500 Rating Details
2023-06-07 15:12:38 -0500 Rating Details
2023-06-07 15:10:14 -0500 Rating Details
2023-06-07 15:08:06 -0500 Rating Details
2023-06-07 15:07:11 -0500 Rating Details
2023-06-07 15:07:10 -0500 Rating Details
2023-06-07 15:06:16 -0500 Rating Details
2023-06-07 14:58:26 -0500 Rating Details
2023-06-07 14:56:37 -0500 Rating Details
2023-06-07 14:54:30 -0500 Rating Details
2023-06-07 14:52:34 -0500 Rating Details
2023-06-07 14:50:46 -0500 Rating Details
2023-06-07 14:49:25 -0500 Rating Details
2023-06-07 14:48:42 -0500 Rating Details
2023-06-07 14:47:17 -0500 Rating Details
2023-06-07 14:46:50 -0500 Rating Details
2023-06-07 14:46:49 -0500 Rating Details
2023-06-07 14:44:15 -0500 Rating Details
2023-06-07 14:43:44 -0500 Rating Details
2023-06-07 14:42:55 -0500 Rating Details
2023-06-07 14:42:38 -0500 Rating Details
2023-06-07 14:41:36 -0500 Rating Details
2023-06-07 14:41:32 -0500 Rating Details
2023-06-07 14:41:13 -0500 Rating Details
2023-06-07 14:40:45 -0500 Rating Details
2023-06-07 14:40:15 -0500 Rating Details
2023-06-07 14:39:59 -0500 Rating Details
2023-06-07 14:39:22 -0500 Rating Details
2023-06-07 14:39:12 -0500 Rating Details
2023-06-07 14:37:48 -0500 Rating Details
2023-06-07 14:30:29 -0500 Rating Details
2023-06-07 14:30:10 -0500 Rating Details
2023-06-07 14:23:39 -0500 Rating Details
2023-06-07 14:22:32 -0500 Rating Details
2023-06-07 14:21:20 -0500 Rating Details
2023-06-07 14:20:57 -0500 Rating Details
2023-06-07 14:12:58 -0500 Rating Details
2023-06-07 14:09:21 -0500 Rating Details
2023-06-07 14:02:30 -0500 Rating Details
2023-06-07 14:00:32 -0500 Rating Details
2023-06-07 13:55:54 -0500 Rating Details
2023-06-07 13:54:15 -0500 Rating Details
2023-06-07 13:54:00 -0500 Rating Details
2023-06-07 13:46:00 -0500 Rating Details
2023-06-07 13:40:27 -0500 Rating Details
2023-06-07 13:37:11 -0500 Rating Details
2023-06-07 13:36:38 -0500 Rating Details
2023-06-07 13:32:08 -0500 Rating Details
2023-06-07 13:30:52 -0500 Rating Details
2023-06-07 13:26:54 -0500 Rating Details
2023-06-07 13:15:39 -0500 Rating Details
2023-06-07 13:14:39 -0500 Rating Details
2023-06-07 13:07:42 -0500 Rating Details
2023-06-07 13:06:01 -0500 Rating Details
2023-06-07 12:57:44 -0500 Rating Details
2023-06-07 12:53:42 -0500 Rating Details
2023-06-07 12:51:03 -0500 Rating Details
2023-06-07 12:49:05 -0500 Rating Details
2023-06-07 12:47:58 -0500 Rating Details
2023-06-07 12:33:00 -0500 Rating Details
2023-06-07 12:28:23 -0500 Rating Details
2023-06-07 12:27:55 -0500 Rating Details
2023-06-07 12:27:53 -0500 Rating Details
2023-06-07 12:27:10 -0500 Rating Details
2023-06-07 12:26:37 -0500 Rating Details
2023-06-07 12:20:15 -0500 Rating Details
2023-06-07 12:17:38 -0500 Rating Details
2023-06-07 12:06:13 -0500 Rating Details
2023-06-07 12:02:46 -0500 Rating Details
2023-06-07 12:02:29 -0500 Rating Details
2023-06-07 11:53:07 -0500 Rating Details
2023-06-07 09:31:30 -0500 Rating Details
2023-06-07 09:13:05 -0500 Rating Details
2023-06-07 08:56:47 -0500 Rating Details
2023-06-07 08:33:33 -0500 Rating Details
2023-06-07 08:18:34 -0500 Rating Details
2023-06-07 07:59:30 -0500 Rating Details
2023-06-07 07:56:13 -0500 Rating Details
2023-06-07 07:54:49 -0500 Rating Details
2023-06-07 07:54:06 -0500 Rating Details
2023-06-08 06:29:04 -0500 Rating Details
2023-06-08 04:40:07 -0500 Rating Details
2023-06-09 06:07:43 -0500 Rating Details
2023-06-10 04:39:14 -0500 Rating Details